Karen Prange, SVP&Pres, Uro & Pelvic Health at BOSTON SCIENTIFIC CORP (BSX), sold 12,432 shares at $16.05 ($200K) on 2016-02-08, disclosed to the SEC on 2016-02-09.
Open-market sale of $200k BSX by SVP&Pres, Uro & Pelvic Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.05 | 6,216 | $100K | 50.0% |
| 2 | $16.05 | 6,216 | $100K | 50.0% |
| Total | $16.05 avg | 12,432 | $200K | 100% |
| Filing → |
| ATRC | SELL | 2025-03-07 | $465K | — | Filing → |
| VRAY | SELL | 2023-07-21 | $9K | — | Filing → |
| ATRC | SELL | 2023-06-12 | $34K | — | Filing → |